America's Healthcare System Ranked Last Among High-Income Nations — Again
The Commonwealth Fund's annual international healthcare comparison has once again placed the US last among 10 high-income nations on overall health system performance, despite spending $4.5 trillion annually — more than any other country on Earth.
America's Opioid Crisis: Fentanyl Deaths Decline for First Time in a Decade Thanks to Naloxone Access
For the first time since 2015, opioid overdose deaths in the United States have declined year-over-year, as widespread naloxone distribution, harm reduction programs, and fentanyl test strips make inroads against the deadliest drug crisis in American history.
ICMR Study: 30-Minute Daily Walk Reduces Heart Disease Risk by 40% in Indians
A landmark ICMR study spanning 10 years and 50,000 participants confirms that a daily 30-minute brisk walk dramatically lowers cardiovascular disease risk in the Indian population.
Psychedelic Therapy Goes Mainstream: FDA Approves Psilocybin Treatment for Depression
The FDA has granted approval for psilocybin-assisted therapy for treatment-resistant depression, opening the door to a new era in American mental health treatment using psychedelic medicines that are proving more effective than any antidepressant ever tested.
Ozempic and Wegovy Transform American Healthcare: 15 Million US Prescriptions and Counting
GLP-1 weight loss drugs have become the fastest-adopted medications in American pharmaceutical history, with 15 million active US prescriptions transforming how doctors and patients approach obesity, diabetes, and heart disease.